Par Drugs And Chemicals Ltd. (PAR): Par Drugs And Chemicals Share Price rises 10.52% to Rs 110.75
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Par Drugs And Chemicals Share Price rose to Rs 110.75 on 31 August 2026, up 10.52% from the previous close of Rs 100.21. The company’s market capitalisation stood at Rs 123.3 crore, placing the move in a clear same-day price rise context. The stock opened at Rs 102.25, touched a high of Rs 112 and a low of Rs 100.26, while turnover was Rs 0.36 crore.
The latest Par Drugs And Chemicals Share Price Today movement confirms a strong upward session, but the supplied data does not establish a company-specific catalyst. For readers tracking Par Drugs And Chemicals Stock News, the most useful near-term lens is whether the stock can hold above the day’s close while investors also review valuation, sector comparison and company financials on Univest.
Par Drugs And Chemicals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 110.75 |
| Previous Close | Rs 100.21 |
| Today's Move | Rs 10.54 (+10.52%) |
| Open | Rs 102.25 |
| High | Rs 112 |
| Low | Rs 100.26 |
| Turnover | Rs 0.36 crore |
| Market Capitalisation | Rs 123.3 crore |
| Market Cap Category | Micro Cap |
Par Drugs And Chemicals Ltd. (PAR) rose to Rs 110.75 from the previous close of Rs 100.21, a move of Rs 10.54 or 10.52%. The stock opened at Rs 102.25, reached a high of Rs 112, recorded a low of Rs 100.26.
Par Drugs And Chemicals share price today recorded a rise of Rs 10.54, or 10.52%, versus the previous close of Rs 100.21. The stock traded between Rs 100.26 and Rs 112 during the session and ended at Rs 110.75. The move came alongside turnover of Rs 0.36 crore. On the numbers alone, this was a notable Par Drugs And Chemicals Share Price update and one of the stronger stock moves in the day’s market snapshot. The verified data confirms the price event, while the reason behind the rise remains unconfirmed in the supplied dataset.
Par Drugs And Chemicals Ltd. (PAR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 123.3 crore |
| P/E Ratio | 8.51x |
| P/B Ratio | 1.06x |
| ROE | 14.47% |
| ROCE | 19.51% |
| EPS | Rs 11.78 |
| Book Value Per Share | Rs 94.84 |
| Dividend Yield | 0% |
Par Drugs And Chemicals Ltd. (PAR) fundamental metrics show P/E 8.51x, P/B 1.06x, ROE 14.47%, ROCE 19.51%. These figures provide context only and are not a buy or sell signal.
Par Drugs And Chemicals Ltd. has a market capitalisation of Rs 123.3 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 8.51x, P/B at 1.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.47% and ROCE of 19.51%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 11.78, book value per share of Rs 94.84, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 8.51x |
| Benchmark Median P/E | 31.21x |
| Benchmark Average P/E | 48.1x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 1.06x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 14.47% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 19.51% |
| Benchmark Median ROCE | 13.6% |
| Company Market Capitalisation | Rs 123.3 crore |
| Benchmark Median Market Cap | Rs 670.73 crore |
Par Drugs And Chemicals Ltd. (PAR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Par Drugs And Chemicals Ltd. (PAR) has a P/E ratio of 8.51x, which is below the benchmark median of 31.21x, a difference of -72.73%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Par Drugs And Chemicals Ltd. (PAR) has a ROE of 14.47%, which is above the benchmark median of 11.78%, a difference of +22.84%. Par Drugs And Chemicals Ltd. (PAR) has a ROCE of 19.51%, which is above the benchmark median of 13.6%, a difference of +43.46%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.09 | 5.33 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 84.12 | 13.93 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 87.81 | 21.34 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 26.24 | 4.39 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.99 | 3.26 | 11.83 | 16 |
Par Drugs And Chemicals Ltd. (PAR) has a P/E ratio of 8.51x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.47% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.51% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Par Drugs And Chemicals Ltd. (PAR) has a market capitalisation of Rs 123.3 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Par Drugs And Chemicals
- The Par Drugs And Chemicals Share Price rose 10.52% to Rs 110.75 in a single session.
- The stock moved from a previous close of Rs 100.21 to a day high of Rs 112.
- Market capitalisation stood at Rs 123.3 crore, which is the company size shown in the supplied data.
- The P/E ratio of 8.51 and P/B ratio of 1.06 place the stock below the industry benchmark median.
- ROE of 14.47% and ROCE of 19.51% are above the same-industry median values in the supplied benchmark set.
About Par Drugs And Chemicals
Par Drugs And Chemicals Ltd. operates in the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry. The supplied data does not break out revenue segments or product lines, so the company profile here is limited to the verified market classification and financial metrics. Even so, the business context is useful: the stock belongs to a regulated, research- and manufacturing-linked industry where valuation often reflects earnings quality, return ratios and scale.
The company’s current market cap of Rs 123.3 crore shows a relatively small listed footprint compared with many sector peers in the same industry set. At the same time, its P/E, P/B, ROE, ROCE, EPS and book value give investors a factual base for comparing Par Drugs And Chemicals Share Price with other Pharmaceuticals & Drugs names on Univest. That makes Par Drugs And Chemicals Stock News relevant not only for the day’s rise, but also for ongoing company overview tracking.
Track Par Drugs And Chemicals Share Price on Univest
Use Par Drugs And Chemicals Ltd. (PAR) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Par Drugs And Chemicals Share Price live on Univest along with key stock data such as valuation ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers review Par Drugs And Chemicals Share Price Today in the wider context of stock analysis, fundamental analysis and peer comparison. For users following Par Drugs And Chemicals Latest News, the platform brings together company financials, market cap context and research-style commentary in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Par Drugs And Chemicals Share Price rise today?
Ans. The supplied data confirms a same-day rise of 10.52% to Rs 110.75, but it does not establish a company-specific catalyst. Investors can still review the close, day range and valuation context in the numbers.
What is Par Drugs And Chemicals Share Price today?
Ans. Par Drugs And Chemicals Share Price today is Rs 110.75. It moved up Rs 10.54 from the previous close of Rs 100.21 and traded within a day range of Rs 100.26 to Rs 112.
What is the market capitalisation of Par Drugs And Chemicals?
Ans. The company’s market capitalisation is Rs 123.3 crore. That figure is below the same-industry benchmark median of Rs 670.73 crore, which provides useful size context for Par Drugs And Chemicals Stock News.
How does Par Drugs And Chemicals look on valuation?
Ans. The stock’s P/E ratio is 8.51 and its P/B ratio is 1.06. Both sit below the supplied same-industry benchmark medians, which helps frame Par Drugs And Chemicals Share Price against peers.
What do ROE and ROCE show for Par Drugs And Chemicals?
Ans. ROE is 14.47% and ROCE is 19.51%. Both are above the same-industry benchmark medians in the supplied set, so the profitability backdrop is stronger than the valuation multiples suggest. ROE stands at 14.47%.
How does Par Drugs And Chemicals compare with Healthcare peers?
Ans. It is much smaller than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla by market cap. Its P/E and P/B are also lower than those listed peer values.
